Unbiased Analysis of Today's Healthcare Issues
That is the title of a Journal of Economic Perspectives article by Martin Gaynor and Amanda Starc (2026). The article provides an overview of the current levels of competition in US health insurance markets, considers theoretic issues in what levels of competition are optimal, what empirical studies have found of the impact of competition and…
When health economics emerged as a distinct discipline in the late 1960s, mainstream academic and policy paradigms widely presumed that competitive market mechanisms were structurally incompatible with medical delivery. Influenced by foundational ideas like Kenneth Arrow’s 1963 landmark paper emphasizing the pervasive friction of clinical uncertainty, early experts argued that society had to look almost…
Last week, the Federal Trade Commission (FTC) increased their required premerger reporting requirements for any healthcare providers such as hospitals. Healthcare Dive reports: Thursday’s update marks the first time the FTC has revised its Hart-Scott-Rodino Act premerger notification form in nearly 50 years.The law is intended to alert officials of companies’ intent to merge and…
From the FTC’s press release out today: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’…
A judge blocked a potential $37 billion deal for the merger of large U.S. health insurers Aetna and Humana. The Washington Post provides some explanation behind the judge’s logic: Bates wrote in his opinion that the proposed merger would have decreased competition substantially in the Medicare Advantage market in 364 counties. Aetna and Humana had argued…